SAT-410 Long Term Evaluation of TSH Receptor Antibodies and Thyroid Stimulating Immunoglobulin After Radioiodine Therapy for Thyrotoxicosis

Background Radioioactive iodine therapy (RAI) is an excellent choice to treat thyrotoxicosis, particularly Graves′ disease (GD) patients. After RAI therapy, it is well known that TSH receptor antibodies (TRAb) rise in GD patients and autoimmunity can eventually surge in patients with toxic multinodu...

Descripción completa

Detalles Bibliográficos
Autores principales: Marui, Suemi, Irigoitia, Bruna, Lenczuk, Aline, Rocha, Nelisa Helena, Brito, Luciana Pinto, Watanabe, Tomoco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207484/
http://dx.doi.org/10.1210/jendso/bvaa046.1301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207484/
http://dx.doi.org/10.1210/jendso/bvaa046.1301

Ejemplares similares